30mg tirzepatide reconstitution: why this query should give you pause

You've found a vial and a guide, here's what that actually means

Picture the scenario: you've found a website selling tirzepatide as a lyophilised powder in a small glass vial, possibly labelled "30mg", alongside a reconstitution guide telling you how much bacteriostatic water to add and what volume to draw for each "dose". It looks clinical. The instructions seem thorough. The price is considerably lower than a Mounjaro pen.

What you're looking at is a tirzepatide compound sold as a "research peptide" or "research chemical", a category that exists to sidestep medicines regulation. These products are not assessed by the MHRA. They carry no authorised patient information leaflet. The concentration you inject depends entirely on your own maths, the accuracy of the manufacturer's stated content, and the sterility of your preparation environment. None of those things can be guaranteed. The MHRA has warned publicly and repeatedly about fake and unlicensed weight-loss injectables circulating online, noting that some have been found to contain unexpected substances, including insulin. You can read the current MHRA guidance on reporting suspect sellers via Yellow Card.

The 30mg figure itself is telling. Mounjaro's highest licensed strength is 15mg per weekly dose. A 30mg vial labelled for "reconstitution" has no reference point in any UK-authorised prescribing documentation. That dose discrepancy alone signals you are outside licensed medicine entirely.

What licensed Mounjaro treatment actually looks like

The contrast is worth spelling out. Eli Lilly manufactures Mounjaro as a pre-filled KwikPen containing four weekly doses. You dial the pen, press the button at the injection site (abdomen, thigh or upper arm), and the mechanism does the rest. There is no powder. No syringe to fill. No calculation required at the point of injection. The NHS tirzepatide medicine page explains the standard injection process in straightforward terms.

Licensed doses start at 2.5mg (a tolerability phase, giving the body time to adjust before the prescriber increases the dose) and move upward through 5mg, 7.5mg, 10mg, 12.5mg and 15mg. Each step is a clinical decision, not something a patient self-manages by adjusting a reconstituted vial. A prescriber reviews your progress before any increase, checking both effectiveness and how well you are tolerating treatment. That oversight exists precisely because tirzepatide is a prescription-only medicine, not a supplement or a freely adjustable compound.

If you are thinking about how the cost of licensed treatment compares, our overview of Mounjaro pricing in the UK sets out what has happened to list prices and what a legitimate private prescription includes. Knowing that context makes the appeal of cheap online vials easier to understand, and easier to weigh against the risks.

Reconstitution charts, calculators and guides: what they really describe

A fair portion of the content you will find about tirzepatide reconstitution charts and reconstitution calculators is written to help people using exactly these unlicensed compounds. The maths involved (how many millilitres of bacteriostatic water to add to achieve a target concentration, how many units on an insulin syringe correspond to a given microgram dose) is genuinely complicated. Errors in that calculation translate directly into errors in the dose injected. Too little, and treatment is ineffective. Too much, and the side-effect profile of a GLP-1 and GIP receptor agonist becomes considerably more severe.

This is a question our prescribers hear with some regularity, usually from people who have been priced out of licensed treatment or been told by a GP they do not meet NHS criteria. The frustration is completely understandable. The NHS rollout of tirzepatide is phased, and plenty of people who would benefit clinically cannot access it on the NHS yet. But the answer to that gap is not an unlicensed vial from an unverified seller. The NICE appraisal of tirzepatide (TA1026) sets out the evidence base for the medicine as it is actually licensed and studied, that evidence was built on the pre-filled pen, not on self-mixed powders.

There are also pages that describe reconstituting tirzepatide at 30mg and related processes in more technical detail. Reading those alongside this page gives you a fuller picture of why the question itself points away from licensed UK care.

The safer route, and what the consultation process involves

If you are considering weight-loss treatment with tirzepatide and a reconstitution guide is what brought you here, the practical alternative is a private prescription through a GPhC-registered pharmacy. No mixing. No calculations at your kitchen table at half-past seven in the morning while the kettle boils. A real prescriber, not an algorithm, reviews your consultation the same day. Mounjaro arrives via tracked DPD delivery in plain packaging, ready to use.

Eligibility for licensed tirzepatide follows the Mounjaro SmPC: adults with a BMI of 30 or above, or 27 and above alongside a weight-related condition such as high blood pressure, high cholesterol, type 2 diabetes or obstructive sleep apnoea. Lower BMI thresholds apply for some ethnic backgrounds under UK clinical guidance. The prescriber assesses the whole picture, not just the number on the scale. You can learn more about how we work, including the identity and weight verification steps we carry out, on our about us page.

If licensed treatment is what you are looking for, our weight-loss treatment overview sets out the options available through nume, and the FAQs cover the questions we get asked most often before a first consultation.